• Chronic Lymphocytic Leukemia and Lymphoma | What I Tell My Patients: Integrating New Research Information into Current Clinical Care — Chronic Lymphocytic Leukemia and Bispecific Antibodies in the Management of Lymphoma

  • Jun 14 2024
  • Durée: 2 h
  • Podcast

Page de couverture de Chronic Lymphocytic Leukemia and Lymphoma | What I Tell My Patients: Integrating New Research Information into Current Clinical Care — Chronic Lymphocytic Leukemia and Bispecific Antibodies in the Management of Lymphoma

Chronic Lymphocytic Leukemia and Lymphoma | What I Tell My Patients: Integrating New Research Information into Current Clinical Care — Chronic Lymphocytic Leukemia and Bispecific Antibodies in the Management of Lymphoma

Écouter gratuitement

Voir les détails du balado

  • Résumé

  • Featuring perspectives from Dr John N Allan, Dr Brad S Kahl, Ms Robin Klebig and Ms Mollie Moran, including the following topics:

    • Introduction (0:00)
    • First-Line Therapy for Chronic Lymphocytic Leukemia (CLL) (11:44)
    • The Impact of Comorbid Conditions on the Choice of First-Line Therapy for Newly Diagnosed CLL (18:08)
    • Toxicities and Other Practical Considerations with Venetoclax-Based Treatment (25:17)
    • The Selection and Sequencing of Therapies for Relapsed/Refractory CLL (35:45)
    • The Tolerability of Available Bruton Tyrosine Kinase (BTK) Inhibitors (40:43)
    • The Potential Role of Therapy Combining BTK Inhibitors and Venetoclax (48:48)
    • Bispecific Antibodies as a Treatment Option for Non-Hodgkin Lymphoma (1:04:19)
    • Cytokine Release Syndrome and Neurotoxicity with Bispecific Antibodies (1:06:25)
    • Other Tolerability and Toxicity Issues with Bispecific Antibody Therapy (1:10:44)
    • Bispecific Antibodies for the Management of Follicular Lymphoma (1:18:19)
    • The Role of Bispecific Antibody Therapy in the Treatment of Diffuse Large B-Cell Lymphoma (1:24:17)
    • Other Practical Considerations with the Use of Bispecific Antibodies (1:40:59)

    NCPD information and select publications
    Voir plus Voir moins
activate_primeday_promo_in_buybox_DT
Troubles et maladies Hygiene & Healthy Living Science
Voir plus Voir moins

Ce que les auditeurs disent de Chronic Lymphocytic Leukemia and Lymphoma | What I Tell My Patients: Integrating New Research Information into Current Clinical Care — Chronic Lymphocytic Leukemia and Bispecific Antibodies in the Management of Lymphoma

Moyenne des évaluations de clients

Évaluations – Cliquez sur les onglets pour changer la source des évaluations.

Évaluations sur Audible.ca

Évaluations sur Amazon.ca
Il n'y a pas encore de critiques pour ce titre.